rs772026265
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_001244710.2(GFPT1):āc.1927A>Gā(p.Thr643Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001244710.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFPT1 | NM_001244710.2 | c.1927A>G | p.Thr643Ala | missense_variant | 19/20 | ENST00000357308.9 | NP_001231639.1 | |
GFPT1 | NM_002056.4 | c.1873A>G | p.Thr625Ala | missense_variant | 18/19 | NP_002047.2 | ||
GFPT1 | XM_017003801.2 | c.2002A>G | p.Thr668Ala | missense_variant | 19/20 | XP_016859290.1 | ||
GFPT1 | XM_017003802.3 | c.1948A>G | p.Thr650Ala | missense_variant | 18/19 | XP_016859291.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFPT1 | ENST00000357308.9 | c.1927A>G | p.Thr643Ala | missense_variant | 19/20 | 5 | NM_001244710.2 | ENSP00000349860.4 | ||
GFPT1 | ENST00000361060.5 | c.1873A>G | p.Thr625Ala | missense_variant | 18/19 | 1 | ENSP00000354347.4 | |||
GFPT1 | ENST00000674507.1 | c.1705A>G | p.Thr569Ala | missense_variant | 17/18 | ENSP00000501332.1 | ||||
GFPT1 | ENST00000674438.1 | c.1657A>G | p.Thr553Ala | missense_variant | 16/17 | ENSP00000501469.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251442Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135896
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461836Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727218
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 08, 2024 | The c.1873A>G (p.T625A) alteration is located in exon 18 (coding exon 18) of the GFPT1 gene. This alteration results from a A to G substitution at nucleotide position 1873, causing the threonine (T) at amino acid position 625 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Congenital myasthenic syndrome 12 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 03, 2018 | This sequence change replaces threonine with alanine at codon 625 of the GFPT1 protein (p.Thr625Ala). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and alanine. This variant is present in population databases (rs772026265, ExAC 0.002%). This variant has not been reported in the literature in individuals with GFPT1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at